Neoss® was founded in 2000 by Fredrik Engman and Professor Neil Meredith, with the objective of “Advancing the Science of Dental Implant Treatment”. Convinced that existing implant systems were too complex, their idea was to create a much simpler and more rationalized solution. Through persistent effort and close collaborations they created a high-quality, optimized implant system. With a limited number of components, the Neoss Implant System has unique design features and a host of excellent advantages for everyone. This ingenuity lies in the patented implant design optimizing stability in all bone qualities and conditions and eliminating the need for separate one- or two-stage designs. The minimal platform concept utilizes only two implant platforms to support diameters in the range 3.25–6.5mm. This also greatly simplifies surgical and prosthetic instrumentation aiding communication within the team and increasing efficiently. The benefits are clear: reducing patient treatment time, optimizing inventory control and superior outcomes for patients. Neoss' head office is located in the UK, with subsidiaries in Australia, Austria, Italy, Germany, Middle East and Africa, New Zealand, Sweden and the United States. We are represented by professional partners in China, Croatia, Japan, Netherlands, Saudi Arabia, Spain, Switzerland, Thailand, Turkey, UAE and more.
Looking for a particular Neoss employee's phone or email?
The Neoss annual revenue was $24.8 million in 2026.
Neil Meredith is the CEO of Neoss.
122 people are employed at Neoss.
The NAICS codes for Neoss are [33, 339].
The SIC codes for Neoss are [38, 384].